Inventor · disambiguated record
Nathaniel Catron
Also filed as: CATRON NATHANIEL · CATRON NATHANIEL D
12 granted patents·14 pending applications·70 citations·filing 2010–2024
90Inventor score
Top patents by PatentIndex Score
26 records- 0194US8722657B2Salts and crystalline forms of an apoptosis-inducing agentCATRON NATHANIEL·Filed 2011·Granted May 13, 2014·26 cites·3 claims
- 0292US9403822B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2015·Granted Aug 2, 2016·9 cites·6 claims
- 0390US2025340550A1Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2024·Application pending·0 cites
- 0487US9006247B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesTAO ZHI-FU·Filed 2011·Granted Apr 14, 2015·11 cites·5 claims
- 0586US10213433B2Solid dispersions containing an apoptosis-inducing agentABBVIE INC·Filed 2014·Granted Feb 26, 2019·8 cites·12 claims
- 0686US8513243B2ABT-263 crystalline formsZHANG GEOFF G Z·Filed 2011·Granted Aug 20, 2013·4 cites·2 claims
- 0785US2025161318A1Solid dispersions containing an apoptosis-inducing agentABBVIE INC·Filed 2024·Application pending·0 cites
- 0884US10730873B2Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2017·Granted Aug 4, 2020·1 cites·9 claims
- 0984US9840502B2Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2015·Granted Dec 12, 2017·2 cites·2 claims
- 1084US9238649B2Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamideABBVIE INC·Filed 2014·Granted Jan 19, 2016·3 cites·2 claims
- 1184US2023312566A1Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2022·Application pending·0 cites
- 1282US8362014B2ABT-263 crystalline formsABBVIE INC·Filed 2010·Granted Jan 29, 2013·2 cites·2 claims
- 1375US2020277291A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2019·Application pending·0 cites
- 1474US2020361932A1Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2020·Application pending·0 cites
- 1573US2020231593A1Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2020·Application pending·0 cites
- 1673US2020255425A1Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2020·Application pending·0 cites
- 1772US2022125796A1Solid dispersions containing an apoptosis-inducing agentABBVIE INC·Filed 2021·Application pending·0 cites
- 1871US8362013B2Salt of ABT-263 and solid-state forms thereofABBVIE INC·Filed 2010·Granted Jan 29, 2013·2 cites·10 claims
- 1971US2019194196A1Salts and crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2019·Application pending·0 cites
- 2064US2019315737A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2018·Application pending·0 cites
- 2162US2019275051A1Solid dispersions containing an apoptosis-inducing agentABBVIE INC·Filed 2019·Application pending·0 cites
- 2261US8927009B2ABT-263 capsuleTONG PING·Filed 2010·Granted Jan 6, 2015·2 cites·36 claims
- 2358US2017096424A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2016·Application pending·0 cites
- 2453US2012277210A1Solid dispersions containing an apoptosis-inducing agentCATRON NATHANIEL·Filed 2011·Application pending·0 cites
- 2537US2010297194A1Formulation for oral administration of apoptosis promoterCATRON NATHANIEL·Filed 2010·Application pending·0 cites
- 2632US8728516B2Stabilized lipid formulation of apoptosis promoterCATRON NATHANIEL·Filed 2010·Granted May 20, 2014·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →